10x Genomics, Inc. TXG
Set alert
At close · Oct 30
After hours · Oct 30, 7:23 PM ET
- YTD
- +329.86%
- 1 year
- +463.59%
- Open
- 73.65
- Prev close
- 81.55
- Mkt cap
- 9.13B
- Vol
- 5.22M
- Avg vol
- 3.37M
- EPS
- -0.59
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 67.42
- High
- 75.77
- Forward P/E
- 913.53
- Beta
- 1.99
- Short ratio
- 3.09
- Inst. own
- 116.04%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 74.05
- 200-d avg
- 40.33
- 1y target
- 77.50
5D chart
Signals (117)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:10 PM | 2 days ago |
| RSI: Oversold | Oct 30, 11:30 AM | 2 days ago |
| RSI: Oversold | Oct 30, 11:00 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:50 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:45 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:40 AM | 2 days ago |
| RSI: Oversold | Oct 30, 10:00 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:45 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:45 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:40 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:40 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:45 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:20 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 11:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:55 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:10 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:00 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:50 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:45 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 9:45 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:40 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:55 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:40 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:55 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:20 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:15 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:10 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:10 AM | 4 days ago |
| RSI: Overbought | Oct 28, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 9:30 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 3:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:50 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:45 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:50 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:15 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:10 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:45 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:20 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:50 AM | 5 days ago |
| RSI: Overbought | Oct 27, 11:05 AM | 5 days ago |
| RSI: Overbought | Oct 27, 10:20 AM | 5 days ago |
| RSI: Overbought | Oct 27, 10:10 AM | 5 days ago |
| RSI: Overbought | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:50 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:30 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:15 PM | 6 days ago |
| RSI: Oversold | Oct 26, 2:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:05 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:45 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:25 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:20 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:15 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:55 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:20 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:40 AM | 6 days ago |
| RSI: Overbought | Oct 26, 11:00 AM | 6 days ago |
News
2 days ago zacks.com
3 Promising Genomics Stocks to Add to Your Portfolio Now
Genomics and synthetic biology are transforming healthcare through precision medicine and gene editing, putting ILMN, QURE and TXG in focus as the markets expand.
4 days ago benzinga.com
Vertiv, Evercore, Brinker, GE HealthCare And Other Big Stocks Moving Higher On Wednesday
U.S. stocks mixed; Dow gained ~100 points. Vertiv jumped 13.3% on strong results and raised guidance; Ultralife soared 145.8% on buyout news.
4 days ago prnewswire.com
10x Genomics to Participate in the 2026 Jefferies Global Healthcare Conference
PLEASANTON, Calif., Oct. 27, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, announced today that…
2 weeks ago gurufocus.com
A Look at 10x Genomics Inc (TXG) After 3.5% Decline -- GF Value $18.31 vs Price $69.86
On October 16, 2026, 10x Genomics Inc (TXG) shares fell 3.5%, bringing the current price to $69.86. The stock has experienced significant price fluctuations, wi
2 weeks ago prnewswire.com
10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 2026
PLEASANTON, Calif., Oct. 13, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, announced it will…
-
2 weeks ago benzinga.com
TD Cowen Maintains Hold on 10x Genomics, Raises Price Target to $70
TD Cowen analyst Dan Brennan maintains 10x Genomics (NASDAQ:TXG) with a Hold and raises the price target from $47 to $70.
-
2 weeks ago benzinga.com
Morgan Stanley Maintains Equal-Weight on 10x Genomics, Raises Price Target to $70
Morgan Stanley analyst Tejas Savant maintains 10x Genomics (NASDAQ:TXG) with a Equal-Weight and raises the price target from $40 to $70.
-
2 weeks ago benzinga.com
Canaccord Genuity Maintains Buy on 10x Genomics, Raises Price Target to $100
Canaccord Genuity analyst Kyle Mikson maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises the price target from $60 to $100.
2 weeks ago fool.com
These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys?
Forget the "Magnificent Seven" in favor of the "Tremendous Three"?
3 weeks ago benzinga.com
Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaffirmed FY26 EPS guidance.
3 weeks ago zacks.com
10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research
TXG teams up with Fred Hutchinson Cancer Center to advance precision oncology through single-cell and spatial technologies targeting two cancer types.
-
3 weeks ago benzinga.com
Barclays Maintains Overweight on 10x Genomics, Raises Price Target to $110
Barclays analyst Luke Sergott maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $52 to $110.
-
3 weeks ago benzinga.com
10x Genomics Partners With Fred Hutchinson Cancer Center Over Use Of Single Cell, Spatial Technologies In Both Solid Tumor And Hematologic Malignancies
10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a multi-project research collaboration with Fred…
3 weeks ago prnewswire.com
10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers
Multi-project collaboration with Fred Hutch Cancer Center spans biomarker discovery in bladder cancer and a single cell approach to residual disease detection in acute myeloid leukemia PLEASANTON,…
3 weeks ago benzinga.com
Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up
Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia, extending its CRISPR bet to 50 sessions.
4 weeks ago defenseworld.net
Torex Gold Targets Growth, C$350M Returns and Morelos Expansion
Torex Gold Resources (TSE: TXG) outlined plans to build on production from its Morelos property in Mexico, advance the Los Reyes development project and return capital to shareholders as it seeks to…
1 month ago benzinga.com
10 Stocks Rally as Rate Hike Bets Collapse on Weak September Jobs
Entegris, Rocket and KLA led premarket gains after September payrolls rose just 29,000 vs. 90,000 expected, cutting bets on a Fed rate hike.
1 month ago zacks.com
10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises
TXG begins Atera shipments as orders top 40 systems, highlighting strong early demand and broad research interest in its spatial biology platform.
-
1 month ago benzinga.com
Leerink Partners Maintains Market Perform on 10x Genomics, Raises Price Target to $90
Leerink Partners analyst Mike Kratky maintains 10x Genomics (NASDAQ:TXG) with a Market Perform and raises the price target from $40 to $90.
-
1 month ago benzinga.com
10x Genomics Begins Commercial Shipments Of Its Transcriptome Analysis Tool Atera
Atera is moving into the hands of researchers around the world, from those scaling existing spatial programs to researchers exploring spatial biology for the first time, across discovery,…
-
1 month ago benzinga.com
10x Genomics Launches NVIDIA-Accelerated Sentira Spatial Analysis, Cutting Spatial Data Processing Times From Hours To Minutes
Sentira Spatial Analysis leverages NVIDIA accelerated computing to cut spatial data processing times from hours to minutes, putting rapid, iterative analysis at the fingertips of every…
1 month ago prnewswire.com
10x Genomics Announces Sentira, a New Computational Platform to Turn Complex Biological Data Into Experimental Conclusions
Sentira Spatial Analysis leverages NVIDIA accelerated computing to cut spatial data processing times from hours to minutes, putting rapid, iterative analysis at the fingertips of every researcher…
1 month ago prnewswire.com
10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' Hands
Extraordinary early global demand, ambitious new research programs and an expansive technology roadmap mark the beginning of a new era for biological understanding PLEASANTON, Calif., Sept. 29, 2026…
-
1 month ago benzinga.com
Piper Sandler Maintains Neutral on 10x Genomics, Raises Price Target to $80
Piper Sandler analyst David Westenberg maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $47 to $80.
1 month ago benzinga.com
This Lexicon Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Analysts initiate coverage: Buy on IonQ ($60), Jack Henry ($193) and 10X Genomics ($110); Overweight Lexicon ($8); In-Line Fortive ($60).
-
1 month ago benzinga.com
Argus Research Initiates Coverage On 10x Genomics with Buy Rating, Announces Price Target of $110
Argus Research analyst John Eade initiates coverage on 10x Genomics (NASDAQ:TXG) with a Buy rating and announces Price Target of $110.
1 month ago defenseworld.net
10x Genomics (NASDAQ:TXG) Stock: Insider Shehnaaz Suliman Sells 5,723 Shares
10x Genomics (NASDAQ: TXG - Get Free Report) Director Shehnaaz Suliman sold 5,723 shares of the business's stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of…
1 month ago defenseworld.net
10x Genomics (NASDAQ:TXG) Stock: Insider Serge Saxonov Sells 25,000 Shares
10x Genomics (NASDAQ: TXG - Get Free Report) CEO Serge Saxonov sold 25,000 shares of 10x Genomics stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average…
1 month ago benzinga.com
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets
Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs that also hold her latest bets.
1 month ago gurufocus.com
10x Genomics Inc (TXG) Shares Surge 3.3% -- What GF Score of 56 Tells Investors
On September 21, 2026, 10x Genomics Inc (TXG) shares rose 3.3% to a current price of $79.10. The stock has seen a remarkable performance over the past year, wit
1 month ago defenseworld.net
Analyzing MindWalk (NASDAQ:HYFT) & 10x Genomics (NASDAQ:TXG)
10x Genomics (NASDAQ: TXG - Get Free Report) and MindWalk (NASDAQ: HYFT - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based…
1 month ago defenseworld.net
HB Wealth Management LLC Invests $285,000 in 10x Genomics $TXG
HB Wealth Management LLC purchased a new stake in 10x Genomics (NASDAQ: TXG) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 7,444 shares of…
1 month ago benzinga.com
Radiant Logistics, Waystar, Forgent Power Solutions And Other Big Stocks Moving Higher On Tuesday
U.S. stocks fell, but Radiant Logistics surged 17.8% after beating Q4 estimates. Waystar, Telix and Forgent also posted strong gains.
-
1 month ago benzinga.com
10x Genomics To Incorporate Lunit's AI-Powered Pathology Platform Into Its Oncology Biomarker Discovery Workflow
Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that 10x Genomics, Inc. (Nasdaq: TXG) will incorporate Lunit's AI-powered pathology…
1 month ago prnewswire.com
Lunit Announces Collaboration with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical Research
10x Genomics, a leader in single-cell and spatial biology, to combine its spatial biology technologies with Lunit's AI-powered H&E pathology analysis to advance oncology biomarker discovery SEOUL,…
-
1 month ago benzinga.com
UBS Maintains Neutral on 10x Genomics, Raises Price Target to $68
UBS analyst Dan Leonard maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $20 to $68.
1 month ago gurufocus.com
10x Genomics Inc (TXG) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 56/100
On September 08, 2026, 10x Genomics Inc (TXG) shares rose 4.7% today, bringing the current price to $65.61. The stock has seen significant volatility over the p
1 month ago zacks.com
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?
TXG's 84% rally is backed by consumables growth, Atera demand and higher guidance, but weak instruments and valuation raise the bar.
2 months ago benzinga.com
Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs
Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the funds worth watching.
-
2 months ago benzinga.com
RBC Capital Initiates Coverage On 10x Genomics with Sector Perform Rating, Announces Price Target of $70
RBC Capital analyst Dan Leonard initiates coverage on 10x Genomics (NASDAQ:TXG) with a Sector Perform rating and announces Price Target of $70.
2 months ago benzinga.com
Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit
10x Genomics won a $4.8 million patent infringement lawsuit against Qiagen subsidiary Parse Biosciences, prompting plans for an injunction.
-
2 months ago benzinga.com
10x Genomics Wins Patent Case Against Parse Biosciences As Jury Finds Willful Infringement And Awards $4.8M+ In Damages; Company To Seek Enhanced Damages, Fees And Permanent Injunction
Jury finds Parse willfully infringed Scale Biosciences' patents and rejects Parse's invalidity challengePLEASANTON, Calif., Aug. 28, 2026 /PRNewswire/ -- 10x Genomics, Inc. (NASDAQ:TXG), the life…
2 months ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
2 months ago benzinga.com
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting strong Q4 results and positive sales guidance.
-
2 months ago benzinga.com
Stephens & Co. Maintains Overweight on 10x Genomics, Raises Price Target to $65
Stephens & Co. analyst Mason Carrico maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $50 to $65.
-
2 months ago benzinga.com
Piper Sandler Maintains Neutral on 10x Genomics, Raises Price Target to $47
Piper Sandler analyst David Westenberg maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $42 to $47.
-
2 months ago benzinga.com
Canaccord Genuity Maintains Buy on 10x Genomics, Raises Price Target to $60
Canaccord Genuity analyst Kyle Mikson maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises the price target from $50 to $60.
-
2 months ago benzinga.com
Citigroup Maintains Neutral on 10x Genomics, Raises Price Target to $50
Citigroup analyst Brendan Digan maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $45 to $50.
-
2 months ago benzinga.com
Morgan Stanley Maintains Equal-Weight on 10x Genomics, Raises Price Target to $40
Morgan Stanley analyst Tejas Savant maintains 10x Genomics (NASDAQ:TXG) with a Equal-Weight and raises the price target from $37 to $40.